医药企业吉利德科学公司抗病毒药物专利分析及其启示  

Patent Analysis and Enlightenment of Antiviral Drugs from Pharmaceutical Company Gilead Sciences

作　　者：许轶[1] 张娴 李姝影[1] 朱月仙[1] XU Yi;ZHANG Xian;LI Shuying;ZHU Yuexian(Chengdu Library and Information Center,Chinese Academy of Sciences,Chengdu 610041,China)

机构地区：[1]中国科学院成都文献情报中心,成都610041

出　　处：《世界科技研究与发展》2021年第2期242-256,共15页World Sci-Tech R&D

基　　金：四川省省级知识产权专项资金“面向四川知识产权高质量发展的决策支撑情报研究与信息服务项目”(2019-ZS-00174)。

摘　　要：吉利德公司借助专利申请、收购等多种运营手段实现了跨越式发展,其专利运营策略受到业内的高度关注。本文分析了吉利德公司抗病毒药物专利申请年度趋势、技术领域、地域分布、在华专利布局,深入解读抗病毒重点药物恩曲他滨和丙通沙的专利和技术信息,据此总结和提炼吉利德公司专利策略的特点。结果表明,吉利德公司专利运营特征包括持续专注研发创新,实施知识产权保护全球化布局策略;通过树立垄断性专利壁垒,保障技术自由实施;灵活处置知识产权资产,以实现专利价值最大化等。我国的药物研发机构和制药企业应当掌握核心技术,构建地域和技术领域的复合专利保护网;对于核心技术已被申请专利的领域,可适时开发或仿制、申请衍生物结构或新用途等外围专利、设计技术规避方案等多种方式制定专利策略。Gilead Sciences, Inc. has achieved leapfrog development with multiple operating methods such as patent applications and acquisitions, and its patent operating strategy has become the focus of attention in the industry. This article analyzes the annual trends, technical fields, geographical distribution, and patent layout of the patent applications of Gilead’s antiviral drugs, conducts an in-depth interpretation of the patents and technical information of key drugs, such as Emtricitabine and Epclusa. And then, this article summarizes and refines the characteristics of Gilead?s patent strategy. The results show that Gilead’s patent operation is characterized by its: continuity to focus on R&D and innovation, and implementation of a global layout strategy for intellectual property protection;guarantee of the freedom to operate(FTO) of technology through the establishment of monopoly patent barriers;the flexible disposal of intellectual property assets to achieve the maximum value of patents. Based on these observations, the research institutions and companies of pharmaceuticals industry in China should master core technologies, and build a composite patent protection network in geographical and technical fields;formulate patent strategies in a variety of ways when core technologies have been patented, such as development or imitation at the right time, and apply for peripheral patents such as derivative structures or new uses, and designing technology circumvention solutions.

关 键 词：吉利德公司 专利策略 抗病毒药物 

分 类 号：F416.72[经济管理—产业经济] F273.1[医药卫生—药学] R95